Skip to main content
. 2015 Jun 1;10(6):e0127072. doi: 10.1371/journal.pone.0127072

Fig 4. TR immuno-positivity predicts prognosis.

Fig 4

Survival of TRα positive vs. negative cases (A, B) and TRβ positive vs. negative cases (C, D) was plotted in accordance with Kaplan-Meier survival curves. TRα was a negative predictor regarding five-year survival of patients carrying a BRCA1 mutation (A). In sporadic cancer cases TRα was not associated with five-year survival (B). TRβ positivity was associated with a significantly prolonged overall survival in patients carrying a BRCA1 mutation (C). In sporadic cancer cases TRβ failed to predict prognosis (D).